LobbyingMid America Transplant lobbying by quarter
Mid America Transplant's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Mid America Transplant
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 2 |
| Q1 2023 | $30K | 2 |
| Q2 2023 | $30K | 2 |
| Q3 2023 | $40K | 2 |
| Q4 2023 | $20K | 2 |
| Q1 2024 | $30K | 2 |
| Q2 2024 | $30K | 2 |
| Q3 2024 | $40K | 2 |
| Q4 2024 | $30K | 2 |
| Q1 2025 | $30K | 2 |
| Q2 2025 | $30K | 2 |
| Q3 2025 | $30K | 2 |
| Q4 2025 | $30K | 2 |
| Q1 2026 | $30K | 2 |
| Q2 2026 | $30K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$430K · 15 reports
- Medicare and Medicaid$30K · 17 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES29 reports
- SENATE29 reports
- Centers For Medicare and Medicaid Services (CMS)18 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Pavea | $460K | 15 quarters |
| Strategic Health Care | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Pavea | $30K |
| 07/17for Q2 | Strategic Health Care | Under $5,000 |
| 04/20for Q1 | Pavea | $30K |
| 04/17for Q1 | Strategic Health Care | Under $5,000 |
| 01/20for Q4 2025 | Pavea | $30K |
| 01/19for Q4 2025 | Strategic Health Care | Under $5,000 |
| 25/10/20for Q3 2025 | Strategic Health Care | Under $5,000 |
| 25/10/17for Q3 2025 | Pavea | $30K |
| 25/07/21for Q2 2025 | Pavea | $30K |
| 25/07/10for Q2 2025 | Strategic Health Care | Under $5,000 |
| 25/04/21for Q1 2025 | Pavea | $30K |
| 25/04/21for Q1 2025 | Strategic Health Care | Under $5,000 |
| 25/01/21for Q4 2024 | Pavea | $30K |
| 25/01/21for Q4 2024 | Strategic Health Care | Under $5,000 |
| 24/10/21for Q3 2024 | Strategic Health Care | Under $5,000 |
| 24/10/01for Q3 2024 | Pavea | $40K |
| 24/07/22for Q2 2024 | Pavea | $30K |
| 24/07/19for Q2 2024 | Strategic Health Care | Under $5,000 |
| 24/04/22for Q1 2024 | Strategic Health Care | Under $5,000 |
| 24/04/16for Q1 2024 | Pavea | $30K |